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Abstract
Purpose
To characterise longitudinal changes in the retinal microvasculature of type 2 diabetes mellitus (T2DM)
as exemplified in a patient with proliferative diabetic retinopathy (PDR) using an adaptive optics
scanning light ophthalmoscope (AOSLO).

Methods
A 35-year-old T2DM patient with PDR treated with scatter pan-retinal photocoagulation at the inferior
retina 1 day prior to initial AOSLO imaging along with a 24-year-old healthy control were imaged in this
study. AOSLO vascular structural and perfusion maps were acquired at four visits over a 20-week period.
Capillary diameter and microaneurysm area changes were measured on the AOSLO structural maps.
Imaging repeatability was established using longitudinal imaging of microvasculature in the healthy
control.

Results
Capillary occlusion and recanalisation, capillary dilatation, resolution of local retinal haemorrhage,
capillary hairpin formation, capillary bend formation, microaneurysm formation, progression and
regression were documented over time in a region 2° superior to the fovea in the PDR patient. An
identical microvascular network with same capillary diameter was observed in the control subject over
time.

Conclusions
High-resolution serial AOSLO imaging enables in vivo observation of vasculopathic changes seen in
diabetes mellitus. The implications of this methodology are significant, providing the opportunity for
studying the dynamics of the pathological process, as well as the possibility of identifying highly sensitive
and non-invasive biomarkers of end organ damage and response to treatment.

Introduction
Diabetic retinopathy (DR) is a common cause of vision loss and blindness in the working age
population,1 affecting nearly 7.7 million Americans age 40 and older in 2010.2 Type 2 diabetes mellitus
(T2DM) is the most common type of diabetes. Its great impact on quality of life and economics have
made the diagnosis and management of T2DM, and the restoration of normal tissue function, an
important focus of medical professionals and public health proponents. Traditionally the diagnosis of DR
has been based upon the detection of microaneurysms (MAs), exudates and haemorrhages using slit
lamp examination, fundus photography, optical coherence tomography, and intravenous fluorescein
angiography. These changes however, become apparent only once there is considerable damage to the
tissue. The ability to detect DR earlier through retinal imaging could help limit or even avoid irreversible
retinal damage and visual loss, and perhaps secondarily, damage to the kidneys, heart and brain.
Recent developments in adaptive optics scanning light ophthalmoscopy (AOSLO) have allowed in
vivo assessment of the retinal microvasculature without the need for exogenous contrast agents, using
motion contrast image processing.3-8 This has enabled detection of early subclinical changes to the
retinal microvasculature from diabetes mellitus,9-11 including, but not limited to, changes in
microvascular lumen diameter and wall-to-lumen ratios, capillary dropout, capillary bend formations,
and increased tortuosity. These collective results suggest that existing clinical classifications, based on
lower-magnification assessment, may not be adequate in detecting early end-organ damage from
diabetes.
Confocal AOSLO imaging can be enhanced by using a multiply scattered light detection scheme to
produce reliable, high contrast structural and perfusion images of the microvasculature, comparable to
those obtained using AOSLO fluorescein angiography.12 These modified AOSLOs have been previously
used to study vascular defects in patients with DR.9, 12 This report adds to previous literature by
employing an AOSLO, modified with a multiply scattered light detection scheme, to study retinal
microvascular changes longitudinally, occurring in a T2DM patient with PDR. Our findings have
significant implications for the study of early microvascular damage from diabetes mellitus and the
search for more sensitive indicators of disease progression and response to treatment.

Methods
Subjects
A 24 year old male (RR_0188) healthy control subject, with a Haemoglobin A1c (HbA1c) of 4.1% was
imaged twice over a span of 36 weeks. The control subject received a complete eye examination,
including dilated fundus examination using Spectralis OCT and Topcon fundus picture. Visual acuity was
measured at 4 m using LogMAR ETDRS charts with the line scoring method. For the control subject,
visual acuity without spectacle correction was 0.0 logMAR (Snellen 6/6 or 20/20) at both visits. No
evidence of retinal pathology or systemic diseases was present. A 35 year old male (RR_0244) with
T2DM of 8 years duration was imaged four times over the course of 20 weeks. Respectively, the study
eye (right eye) and the fellow eye (left eye) was diagnosed with moderate proliferative diabetic
retinopathy (PDR) and non-proliferative diabetic retinopathy (NPDR) by our in-house retina specialist 9
months prior to the first AOSLO imaging session and was under medical treatment with Novolog Flex
Pen 15 units 3 times per day. The patient received green diode laser pan-retinal photocoagulation to the
inferior retina of the right eye 1 day prior to the first AOSLO imaging visit (spot size 200 μm; pulse

duration 0.2 s; no. of spots 856). No additional pan‐retinal photocoagulation treatment was given over
the course of 20 weeks. Both eyes had a normal anterior segment with clear crystalline lens and ocular
media. Haemoglobin A1c (HbA1c) values of 12.1% and 11.3% were recorded at the first and last
visits (Table 1). Visual acuity with the patient's spectacles was 0.0 logMAR (Snellen 6/6 or 20/20) at all
four visits and no subjective refraction was performed. No other systemic disease, including
hypertension and hyperlipidaemia was reported by the patient.
Table 1. Visit information for the 35 year old diabetic patient
imaging
Visit 1

Visit 2

Visit 3

Visit 4

Bas,eline

4 weeks

14 weeks

20 weeks

Vis ua l Acui;ry (logMAR]

0.0

0.0

0.0

0.0

HbA1c

12.196

ot ,a ke n

Bloo,d Press re (mm Hg)

119/ 60

ot ,a ke n

o . of W.e eks

ot ,a ke n
105/64

11.3%

gsno

HbA1c, haemoglobin A1c.
The normal HbA1c level range is 4.5–6%

AOSLO imaging was performed on the left eye of the control subject and the right eye of the PDR
patient. Pupils were dilated with one drop of 2.5% phenylephrine hydrochloride ophthalmic solution and
1% tropicamide ophthalmic solution. Written informed consent was obtained after the nature and
potential risks of the procedure were explained. This study adhered to the tenets of the Declaration of
Helsinki and was approved by the Institutional Review Board of the New York Eye and Ear Infirmary of
Mount Sinai.

Preliminary ocular imaging
For the PDR patient, intravenous fluorescein angiography was performed 1 month prior to the first
AOSLO visit using the Optos 200Tx (http://www.optos.com). Regions of interest for AOSLO imaging
were pre-identified using the intravenous fluorescein angiography. Spectral domain optical coherence
tomography (SD-OCT) (http://www.heidelbergengineering.com/us/products/spectralis-models/) and
colour fundus photography (http://www.topconmedical.com/products/3doct2000.htm) were also
performed on both subjects at all visits. Axial length measurements were obtained using an IOL Master
(http://www.zeiss.com/meditec) during the first visit.

AOSLO imaging
In vivo retinal microvasculature imaging was performed using a custom-built AOSLO system13 modified
with a multiply scattered light detection scheme. AOSLO offset pinhole reflectance imaging of retinal
microvasculature has been extensively described in previous reports.4, 8 Briefly, the technique involves
displacement of a larger confocal pinhole, located at the retinal plane conjugate in front of the detector.
In this study, the confocal pinhole size was approximately 16.67× the Airy disk diameter, as measured at

the detector plane. Retinal microvasculature contrast was maximised by manually displacing the
confocal pinhole along the horizontal direction only. Imaging was performed at a frame rate of 15 Hz.
The imaging light source was a superluminescent laser diode with a peak wavelength centred at 790 nm
(www.superlumdiodes.com). Light exposure calculations were determined to be well below the
maximum permissible exposure according to the American National Standards Institute ANSI Z136.14
During imaging, subjects were stabilised and secured using a dental impression on a bite bar (Splash!
putty, www.denmat.com). Subjects were instructed to direct their gaze upon a green internal fixation
target. In the control subject, microvascular images were obtained at 1.5° superior to the fovea
(Figure 1). In the PDR patient, three regions of interest were imaged and monitored over the course of
20 weeks: (1) 2° superior to the fovea, (2) 2° inferior to the fovea, and (3) 1.5° nasal to the fovea
(Figure 2a). Throughout the imaging sessions, subjects were encouraged to blink frequently to maintain
their normal tear film, and were provided with short breaks at regular intervals or upon requested.

Figure 1 (a1 and b1) AOSLO structural images of the capillary network approximately 1.5° superior to the fovea,
obtained 36 weeks apart in a 24 year old male healthy control, showing relatively uniform foveal capillary network
and lumen diameters with no significant changes. (a2 and b2) Corresponding perfusion maps generated using a
motion contrast technique. Arteriole and venule are marked as red and blue, respectively. Asterisks indicate the
foveal avascular zone. Scale bar = 50 μm across.

Figure 2 Clinical retinal images of a 35 year old male PDR patient with T2DM. (a) Fundus photograph with regions
of interest on the right eye imaged by AOSLO, as presented in Figures 3, 4 and10. Black arrow indicates location of
vertical SD-OCT scanning. (b) Intravenous fluorescein angiography showing scattered MAs with a temporal region
of capillary nonperfusion (yellow arrow) and neovascularisation (red arrow) with leakage (blue arrow) at and
around the disc. (c) Vertical SDOCT scans through the fovea across the four visits.

AOSLO image sequences collected at each retinal location and focus were registered offline. They were
averaged to maximise signal-to-noise ratio, formatted into microvascular structural maps, and
processed to identify blood cell motion, creating motion contrast perfusion maps, as previously
described.3 Montages of the AOSLO images were generated using Adobe Photoshop CS6
(www.adobe.com). Retinal magnification adjustments were applied to the AOSLO images incorporating
the measured axial lengths into the Emsley schematic eye model formula.15

Capillary diameter and microaneurysm area measurements
Before AOSLO imaging, arterioles and venules near the foveal avascular zone were pre-identified on the
wide field fundus pictures. Capillaries were defined as the smallest blood vessels connecting the
arterioles and venules on the AOSLO images. The foveal avascular zone effective diameter in the control
and the PDR patient was 450 and 570 μm, respectively. Capillary diameter measurements were
obtained near the margin of the foveal avascular zone in both subjects. In this study, capillary wall
imaging was not always possible using the current offset pinhole technique. Thus, capillary diameter was
defined as the total diameter of capillaries. Capillary diameter measurements were obtained on four to
five capillaries near the foveal avascular zone on each studied region per visit. For each capillary,
approximately 10 diameter measurements were performed manually using MATLAB
(www.mathworks.com), resulting in 40–50 capillary diameter measurements on each studied region
per visit. The capillary diameters for PDR vs control were compared using an unpaired t-test.
Nonperfused capillaries, identified from comparison of structural and motion contrast perfusion maps,

were avoided in these measurements. Microaneurysms (MAs) were also delineated manually, using a
MATLAB algorithm.

Results
Repeatability of AOSLO imaging on the control subject
AOSLO imaging of the control subject was performed in a region approximately 1.5° superior to the
fovea (Figure 1) over an interval of 36 weeks. The foveal capillary networks and lumen diameters imaged
in both visits appeared uniform and identical, without evidence of change in perfusion status using both
the structural images and the motion contrast perfusion maps (Figure 1).

Preliminary ocular imaging of the PDR patient
In the PDR patient, intravenous fluorescein angiography obtained 1 month prior to AOSLO imaging,
revealed numerous MAs, an area of temporal capillary non-perfusion, leakage and neovascularisation
involving the optic disc, and lesions of neovascularisation elsewhere in the right eye (Figure 2b).
Intravenous fluorescein angiography of the left eye showed numerous MAs, leakage, and
neovascularisation involving the optic disc.
Although no intraretinal microvascular abnormality, changes in neovascularisation, or soft exudates
were detected in the right eye over the course of four visits, fundus photographs revealed multiple
microaneurysm appearances and disappearances. A small flame haemorrhage inferior to the optic disc
was observed at the second visit that had resolved by the third visit. No noticeable foveal change was
detected on fundus photography over time.
No clinically significant oedema of the macular region or changes in retinal thickness were detected in
either eye on SD-OCT examination across the four imaging visits. Figure 2c shows the SD-OCT scans of
the right eye across the four visits.

PDR microvascular abnormalities at 2° inferior to the fovea
Figure 3 shows AOSLO structural images and motion contrast maps obtained 2° inferior to the fovea of
the PDR patient. Qualitatively, uniform and identical capillary plexus were identified at each visit with
the exception of two cystic structures with a diameter of ~30 μm noted at visit 4 (Figure 3d1, white
arrow) and a dilation of a capillary over time (Figure 3a1–d1, black arrows). No motion of cells within
the two microcysts was visualised on the AOSLO videos. Neither fundus photography nor SD-OCT was
able to detect the microcysts. All imaged capillaries appeared perfused without evidence of occlusion or
outpouching.

Figure 3 AOSLO structural images of a venule obtained approximately 2° inferior to the fovea in the PDR patient.
Imaged region corresponds to the white box on Figure 1a. Left column shows AOSLO structural images of four
visits. Overall, relatively stable microvascular structure was identified over time with the exception of a capillary
dilation (a1–d1, black arrows) and two microcysts (d1, white arrow). Right column shows the corresponding
motion contrast perfusion map. Scale bar = 50 μm across.

PDR microvascular abnormalities at 2° superior to the fovea
A variety of retinal microvascular abnormalities were readily observed on the AOSLO images taken 2°
superior to the fovea of the PDR patient. Compared to the healthy control images (Figure 1), PDR images
showed the presence of nonperfused capillaries, MAs, vessel loops, engorged and dilated blood vessels,
vascular tortuosity, and irregular capillary diameters (Figure 4). Dynamic pathological changes to the
retinal microvasculature in the PDR patient across the four visits included capillary occlusion and
recanalisation (Figure 5), capillary dilation (Figure 6), formation of a capillary bend (Figure 7), resolution
of local retinal haemorrhage (Figure 8), and hairpin capillary formation (Figure 8).

Figure 4 Longitudinal microvascular changes in PDR. AOSLO structural images (left column) and motion contrast
perfusion maps (right column) obtained approximately 2° superior to the fovea. Imaged region corresponds to the
yellow box on Figure 1a. Vessel abnormalities such as nonperfused capillary, microaneurysm, and capillary loops
are visible. Scale bar = 50 μm across. Selected regions are shown in higher magnification in Figures 5-8.
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Figure 5 Recanalisation of an occluded capillary. Magnified region from Figure 4. Top row shows AOSLO structural
images. Bottom row shows corresponding motion contrast perfusion maps. (a1) Black arrow indicates a capillary
segment with an abrupt end. (a1–d1) White arrows indicate that as the neighbouring capillary is recanalised and
reperfused (yellow arrows), vessel calibre and distortion decrease. Scale bar = 50 μm across.
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Figure 6 Capillary dilation after recanalisation and reperfusion. Magnified region from Figure 4. Top row shows
AOSLO structural images. Bottom row shows corresponding motion contrast perfusion maps. A small MA can be
seen along a dilated capillary (a1 and b1, white arrows). Regressed MA after capillary recanalisation and
reperfusion (c1 and d1, white arrows). Yellow arrows indicate capillary dilation due to recanalisation and
reperfusion after the first two visits. Scale bar = 50 μm across.
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Figure 7 Formation of capillary bends. Magnified region from Figure 4. Top row shows AOSLO structural images.
Bottom row shows corresponding motion contrast perfusion maps. Arrows indicate the formation of capillary
bends. Scale bar = 25 μm across.
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Figure 8 Haemorrhage absorption and hairpin formation. Magnified region from Figure 4. Top row shows AOSLO
structural images. Bottom row shows corresponding motion contrast maps. (a1) White arrow indicates a possible

focal haemorrhage located superficially to the imaged vessels compromising its visibility at baseline. (b1–d1)
Formation of hairpin capillaries near the insult (black arrows). Scale bar = 50 μm across.

Capillary occlusion and recanalisation
Dynamic capillary occlusion and recanalisation were observed at two regions (Figures 5 and6).
The first region showed a dilated capillary loop (Figure 5a1, white arrow) and a capillary segment which
ended abruptly (Figure 5a1, black arrow). Comparison between the structural image and the
corresponding motion contrast perfusion map suggested that this capillary segment was occluded at
visit 1 (Figure 5a1,a2, yellow arrows). A capillary segment adjacent and directly connected to the
occlusion was observed to be dilated and distorted with increased tortuosity (Figure 5a1, white arrow).
The occluded capillary from visit 1 was observed to recanalise at visit 2 (Figure 5b1,b2, yellow arrows),
and remained perfused at visits 3 and 4. The dilation and distortion of the adjacent capillary segment
regressed gradually after recanalisation (Figure 5b1,c1,d1, white arrows).
A second region, approximately 100 μm inferior to the first region showed a capillary with a focal bulge
(Figure 6a1, white arrow) adjacent to a nonperfused capillary segment (Figure 6a1, yellow arrow) that
progressed into a saccular microaneurysm by visit 2 (Figure 6b1, white arrow), but had disappeared by
visits 3 and 4 after recanalisation of the nonperfused capillary segment (Figure 6c1,d1, white arrows).
Similar to the first region, the occluded capillary from visit 1 (Figure 6a1,a2, yellow arrows) was
recanalised and dilated at visit 3 (Figure 6c1,c2, yellow arrows), and remained perfused at visit 4. No
neovascularisation was detected in these two perifoveal regions, although some capillaries were
abnormally dilated and tortuous.

Modulation of vessel diameter and capillary bend formation
At the capillary occlusion site, dilation of the capillary diameter was observed in the recanalised capillary
segments (Figures 5 and 6, yellow arrows). There was a capillary bend formation upstream to the site of
capillary occlusion in Figure 5. This capillary bend gradually progressed with increasing vessel length and
diameter (Figure 7, white arrows) over 20 weeks.

Haemorrhage absorption
Figure 8a1 (white arrow) shows a possible focal haemorrhage located superficially to the imaged vessel,
compromising its visibility. The haemorrhage may have been associated with VEGF-mediated
neovascular changes near the insult and the formation of hairpin capillaries (Figures 8b1,c1,d1, black
arrows).

Capillary diameter measurement
Figure 9 shows the capillary diameter measurements obtained in the healthy control and PDR patient
over time. While the mean of capillary diameter was 5.78 ± 1.5 μm (range: 4–9 μm) in the control
subject, the mean of capillary diameter in the PDR patient was higher, with 7.7 ± 2.2 μm in the inferior
region and 10.0 ± 3.2 μm in the superior region. Although a range of 4–9 μm capillary diameters was
measured in the normal subject, a wide range of 5–30 μm was observed within the superior region of
the PDR patient. The mean of capillary diameters measured at the PDR superior and inferior region were
significantly higher than that of the control (unpaired t-test, p < 0.05). Capillary diameter measurements
varied over the course of the study in both inferior and superior regions of the PDR patient. In the
inferior and superior regions, respectively, capillary diameter initially decreased by 7% and 9% at visit 2,

then increased by 7% and 13% at visit 3, followed by a 4% and 5% reduction at visit 4. In contrast, a 2%
difference of the capillary diameter measurements was reported in the control subject over 36 weeks.
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Figure 9 Capillary diameter measurements over time in the PDR patient and healthy control. Error bars represent
standard deviation. Square and circle data points have been displaced slightly to the right for better visualisation of
the error bars.

Microaneurysm development
MA formation, progression, and regression were clearly identified 1.5° nasal to the fovea in the PDR
patient across visits (Figure 10). Four MAs were imaged and monitored over time. The walls of all of the
MAs remained transparent with visible blood flow in the AOSLO structural image sequence. No lumen
clots were detected. Two types of MA morphologies were observed – focal bulge and
saccular,16, 17 ranging in size from 200–700 μm2. At baseline visit 1, only one focal bulge MA (Figure 10a1,
white arrow) was detected with relatively uniform capillary network and lumen diameter in the
neighbouring region. No images were collected at visit 2 in this region. At visit 3, while three saccular
MAs with various sizes were formed adjacent to the focal bulge MA (Figure 10b1, black arrows), the
focal bulge MA appeared to have regressed (Figure 10b1, white arrow). By visit 4, as one of the saccular
MAs seemed to have progressed in size by 27%, two other saccular MAs had regressed by 25% & 38%
(Figure 10c1). Also visualized at visit 4 was the complete regression of the focal bulge MA without any
evidence of thrombogenesis (Figure 10, white arrows).

Figure 10 MA formation, progression, and regression located at 1.5° nasal retina in the PDR patient. (a1, b1, and
c1) AOSLO structural images over time. Black arrows indicate saccular MA formation over time. White arrows show
a focal bulge MA and regression over time. (a2, b3, and c3) corresponding motion contrast perfusion maps.
Asterisks indicate the foveal avascular zone. Scale bar = 50 μm across.

Discussion
Longitudinal AOSLO imaging over 20 weeks in a T2DM patient with PDR revealed various microscopic
sub-clinical vascular changes, not detectable with current clinical OCT technology. These findings
illustrate that vascular change can be highly dynamic, with microscopic changes such as capillary
recanalisation and reperfusion, capillary dilation, and MA development occurring week to week, despite
apparently stable visual acuity and SD-OCT. We must caution the reader however, as it is unclear
whether these changes are representative of the natural history of diabetic retinopathy since the PDR
patient was treated with pan-retinal photocoagulation prior to imaging. In general, the structural and
motion contrast perfusion images obtained using AOSLO modified with a multiply scattered light
detection scheme enabled us to detect nonperfused capillaries, which is not possible using vascular
imaging techniques that depend on the use of contrast agents.

Capillary diameter
AOSLO imaging modified with multiply scattered light detection provides high contrast structural images
of the retinal vasculature, enabling measurements of capillary diameter.4, 9 Our findings of capillary
diameter measured in the healthy control eye are in close agreement with those reported by
histological studies reported in macaque monkeys.18, 19 Compared to the control subject, our results of
larger capillary diameter in the PDR patient are similar to those in a previous report on NPDR patients
using similar approach.9

Haemodynamics
It is well known from histopathological studies that diabetes mellitus is associated with endothelial and
pericyte cell death, and basement membrane thickening,20-22 leading to capillary occlusion with

development of retinal ischemia. The presence of capillary occlusion in the inner retinal plexus is
considered a critical sign of DR.23, 24 In our study, two distinct examples of capillary segments with
occlusion and recanalisation were found (Figures 5 and6). While both capillary segments showed
occlusion at Visit 1, one capillary segment showed subsequent recanalisation and re-establishment of
near-normal structure at Visit 2–4 (Figure5). Another capillary segment showed a more tortuous and
dilated course after recanalisation and reperfusion at Visits 3–4 (Figure 6c1,d1, yellow arrows). Notably,
this recanalisation event should not be confused with neovascularisation. While recanalisation indicates
a restoration of local perfusion, neovascularisation occurs once there is damage of downstream tissue
with high VEGF release resulting in an ill-fated attempt to rescue dying surrounding tissue. It is difficult
to speculate on what effect the process of recanalisation has on the overall health of the retina.
Although recanalisation suggests at least partial functional recovery of the blood vessel, reperfusion
injury to the surrounding tissue may occur.25, 26
Although this study explores results obtained in one PDR patient, the observed capillary abnormalities
and associated retinal hypoxia were consistent with prior studies.24, 27 In attempting to explain our
results of vascular remodelling due to capillary occlusion and recanalisation, we speculated that as the
adjacent capillary is occluded, it causes an increase in the neighbouring intravascular hydrostatic
pressure. It is possible that the neighbouring perfused capillary, with an already compromised vascular
wall structure, became dilated via mechanical stretching as a result of this increased hydrostatic
pressure (Figures 5a1 and6a1,b1). Once the occluded capillary became recanalised and reperfused, the
hydrostatic intravascular pressure equilibrated, resulting in a less dilated and distorted capillary in the
adjacent segment (Figures 5b1–d1 and 6c1–d1). The remaining tortuosity and dilation of the recanalised
capillary suggests the presence of compromised vascular wall structure due to malfunction of pericytes
and endothelial cells. It is anticipated that with the addition of an imaging frame rate of ~120 fps or
higher,28, 29 AOSLO may provide quantitative measurements of capillary blood flow at or near the
affected regions. Our findings may offer insight into the pathophysiology of microvascular damage in DR.

Microaneurysm development
Retinal MAs have been used clinically as an indicator for monitoring disease progression and treatment
response.30-33 In particular, absolute count 34, 35 and turnover36, 37 of MAs can be used as an indicator for
disease progression and reflect the severity of retinopathy.38 Prior studies have also shown that the total
number of retinal MAs correlates with the HbA1c level in patients with T2DM.37, 39 Although many
aspects of MAs have been studied extensively using histological and clinical approaches, the dynamics of
MA development remains unclear.17 Figure 10 shows a series of events representing the development of
MAs in the PDR patient over 20 weeks. A total of 4 MAs were imaged and monitored. Only one MA was
visible at visit 1 (Figure 10, MA no. 3) surrounded by a relatively normal looking capillary network
without any noticeable capillary wall bulges. By visit 3, three new MAs had formed (Figure 10, MA no. 1,
2, & 4) with relatively tortuous neighbouring capillaries, suggesting early stages of MA formation. Our
findings agree with prior studies that have shown that MAs are dynamic lesions which undergo
formation and regression.40 Tracking MAs over time may serve as a biomarker of vascular stability
revealing disease progression or treatment response. Our longitudinal images are able to document the
life cycle of individual MAs through their stages of development noninvasively using AOSLO.

Conclusions
AOSLO provides direct and noninvasive visualisation of the retinal microvasculature of healthy and DR
retina, which when performed longitudinally opens the opportunity for new insights into the dynamics
of vascular disease. Use of this imaging technique may facilitate identification of more sensitive
indicators of DR progression based upon microvascular features. Future studies should include a larger
sample size with appropriately matched healthy controls and imaging visit intervals. Hopefully, our
findings will serve as a template for future studies focused on dynamics of retinal microvasculature in
the pathogenesis of DR.
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